Enjoy complimentary customisation on priority with our Enterprise License!
Below are some of the key findings from this pancreatic cancer therapeutics market analysis report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
The rising prevalence of pancreatic cancer in developed countries due to the lack of therapeutic approaches for early-stage detection is driving the pancreatic cancer therapeutics market. The high incidence of pancreatic cancer leads to germline mutations which cause the defective genes to pass from parents to children, making the early detection of pancreatic cancer important, leading to the growth of the pancreatic cancer therapeutics market.
The increasing demand for targeted therapy is another factor driving the growth of the pancreatic cancer therapeutics market. Targeted therapy singles out specific receptors that are present in the cancer cells and does not harm the peripheral healthy cells of the body unlike the traditional therapeutics method like chemotherapy. The rising prevalence of pancreatic cancer coupled with increasing demand for targeted therapy is driving the pancreatic cancer therapeutics market growth at a CAGR of more than 8% during the forecast period.
The global pancreatic cancer therapeutics market is extremely concentrated. The market is in the growth phase, and the competition is expected to become intense by the end of the forecast period. To help clients improve their revenue shares in the market, this research report provides an analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this pancreatic cancer therapeutics market analysis report suggests strategies companies can follow and recommends key areas they should focus on, to make the most of upcoming growth opportunities.
The report offers a detailed analysis of several leading companies, including:
Targeted therapy was dominating the global pancreatic cancer therapeutics market in 2018. The market share of this segment will increase, and it will continue to dominate the market throughout the next five years.
The Americas accounted for the largest pancreatic cancer therapeutics market share in 2018. This region will witness an increase in its market share and remain the market leader for the next five years.
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: PIPELINE ANALYSIS
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY PRODUCT
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY TYPE
PART 10: GEOGRAPHIC LANDSCAPE
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.